chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Blood test, Chest X-ray, Chest discomfort, Dyspnoea
Clinical narrative: Chest tightening less than 10 minutes after injection. Heart palpitations with shortness of breath. Onset of insomnia, anxiety, and panic still going on currently.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram, Insomnia, Palpitations, Panic attack
Clinical narrative: Chest tightening less than 10 minutes after injection. Heart palpitations with shortness of breath. Onset of insomnia, anxiety, and panic still going on currently.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Vaccinated pt admitted with covid infection
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Chills, Cough
Clinical narrative: I had a breakthrough covid infection in February 2022. Sick for 2 weeks, fever, chills, sinus congestion, headaches, cough, body aches, loss of taste and smell, brain fog, and fatigue
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Headache, Illness, Pain
Clinical narrative: I had a breakthrough covid infection in February 2022. Sick for 2 weeks, fever, chills, sinus congestion, headaches, cough, body aches, loss of taste and smell, brain fog, and fatigue
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Sinus congestion
Clinical narrative: I had a breakthrough covid infection in February 2022. Sick for 2 weeks, fever, chills, sinus congestion, headaches, cough, body aches, loss of taste and smell, brain fog, and fatigue
Age: 1.25
Sex: F
Vaccine: DTAPIPV
Symptoms: Wrong product administered
Clinical narrative: Pt was given Kinrix instead of ordered infinrix
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Vaccinated pt admitted with covid infection
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Fall, Headache, Hypoaesthesia, Joint injury, Nausea
Clinical narrative: I had usual symptoms, fever, headache, nausea. Then I felt like i was going to be sick (vomit) arouns 3 a.m.  When i tried to stand, i had no feeling in my legs and I went down. Ended up breaking my right wrist. My husband was up too. He said I turned pale befoe I went down.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pallor, Pyrexia, Wrist fracture, X-ray
Clinical narrative: I had usual symptoms, fever, headache, nausea. Then I felt like i was going to be sick (vomit) arouns 3 a.m.  When i tried to stand, i had no feeling in my legs and I went down. Ended up breaking my right wrist. My husband was up too. He said I turned pale befoe I went down.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Anticoagulant therapy, Anxiety, Asthenia, COVID-19 pneumonia
Clinical narrative: Admit date 9/13/21 Pt admitted for acute respiratory failure and COVID PNA;  Comprehensive problem list: acute hypoxemic respiratory failure, refractory hypoxemia, COVID PNA,  cardiac arrest, coronary artery disease status post CABG, probable pulmonary embolus, colitis, COPD on home O2, chronic hypoxemic resp failure, insulin dependent diabetes mellitus, depression, GERD, hypertension, anxiety and panic attack Pt has end stage renal disease; had fever and weakness; O2 saturation was 70% on 3L cannula that he wore all the time; treated with vapotherm and non-rebreather mass which was ineffective; switched to bipap which worked well in the er; transferred to icu; became hypoxemic; intubated with 7.5 ET tube and arrested 10 min later; cpr ensued, 4 separate codes because of recurrent problems ekg showed some nonspecific st-t changes; heparin given, low oxygen levels that could not be increased, 2nd arrest, cpr given; sister was called, determined that no further cpr would be given; allowed to have continued support until his heart quit and pt passed away.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac arrest, Chronic obstructive pulmonary disease, Chronic respiratory failure, Colitis, Coronary artery bypass
Clinical narrative: Admit date 9/13/21 Pt admitted for acute respiratory failure and COVID PNA;  Comprehensive problem list: acute hypoxemic respiratory failure, refractory hypoxemia, COVID PNA,  cardiac arrest, coronary artery disease status post CABG, probable pulmonary embolus, colitis, COPD on home O2, chronic hypoxemic resp failure, insulin dependent diabetes mellitus, depression, GERD, hypertension, anxiety and panic attack Pt has end stage renal disease; had fever and weakness; O2 saturation was 70% on 3L cannula that he wore all the time; treated with vapotherm and non-rebreather mass which was ineffective; switched to bipap which worked well in the er; transferred to icu; became hypoxemic; intubated with 7.5 ET tube and arrested 10 min later; cpr ensued, 4 separate codes because of recurrent problems ekg showed some nonspecific st-t changes; heparin given, low oxygen levels that could not be increased, 2nd arrest, cpr given; sister was called, determined that no further cpr would be given; allowed to have continued support until his heart quit and pt passed away.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Coronary artery disease, Death, Depression, Electrocardiogram ST-T change, End stage renal disease
Clinical narrative: Admit date 9/13/21 Pt admitted for acute respiratory failure and COVID PNA;  Comprehensive problem list: acute hypoxemic respiratory failure, refractory hypoxemia, COVID PNA,  cardiac arrest, coronary artery disease status post CABG, probable pulmonary embolus, colitis, COPD on home O2, chronic hypoxemic resp failure, insulin dependent diabetes mellitus, depression, GERD, hypertension, anxiety and panic attack Pt has end stage renal disease; had fever and weakness; O2 saturation was 70% on 3L cannula that he wore all the time; treated with vapotherm and non-rebreather mass which was ineffective; switched to bipap which worked well in the er; transferred to icu; became hypoxemic; intubated with 7.5 ET tube and arrested 10 min later; cpr ensued, 4 separate codes because of recurrent problems ekg showed some nonspecific st-t changes; heparin given, low oxygen levels that could not be increased, 2nd arrest, cpr given; sister was called, determined that no further cpr would be given; allowed to have continued support until his heart quit and pt passed away.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Endotracheal intubation, Gastrooesophageal reflux disease, Hypertension, Hypoxia, Intensive care
Clinical narrative: Admit date 9/13/21 Pt admitted for acute respiratory failure and COVID PNA;  Comprehensive problem list: acute hypoxemic respiratory failure, refractory hypoxemia, COVID PNA,  cardiac arrest, coronary artery disease status post CABG, probable pulmonary embolus, colitis, COPD on home O2, chronic hypoxemic resp failure, insulin dependent diabetes mellitus, depression, GERD, hypertension, anxiety and panic attack Pt has end stage renal disease; had fever and weakness; O2 saturation was 70% on 3L cannula that he wore all the time; treated with vapotherm and non-rebreather mass which was ineffective; switched to bipap which worked well in the er; transferred to icu; became hypoxemic; intubated with 7.5 ET tube and arrested 10 min later; cpr ensued, 4 separate codes because of recurrent problems ekg showed some nonspecific st-t changes; heparin given, low oxygen levels that could not be increased, 2nd arrest, cpr given; sister was called, determined that no further cpr would be given; allowed to have continued support until his heart quit and pt passed away.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Oxygen saturation decreased, Panic attack, Positive airway pressure therapy, Pulmonary embolism, Pyrexia
Clinical narrative: Admit date 9/13/21 Pt admitted for acute respiratory failure and COVID PNA;  Comprehensive problem list: acute hypoxemic respiratory failure, refractory hypoxemia, COVID PNA,  cardiac arrest, coronary artery disease status post CABG, probable pulmonary embolus, colitis, COPD on home O2, chronic hypoxemic resp failure, insulin dependent diabetes mellitus, depression, GERD, hypertension, anxiety and panic attack Pt has end stage renal disease; had fever and weakness; O2 saturation was 70% on 3L cannula that he wore all the time; treated with vapotherm and non-rebreather mass which was ineffective; switched to bipap which worked well in the er; transferred to icu; became hypoxemic; intubated with 7.5 ET tube and arrested 10 min later; cpr ensued, 4 separate codes because of recurrent problems ekg showed some nonspecific st-t changes; heparin given, low oxygen levels that could not be increased, 2nd arrest, cpr given; sister was called, determined that no further cpr would be given; allowed to have continued support until his heart quit and pt passed away.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Resuscitation, Type 1 diabetes mellitus
Clinical narrative: Admit date 9/13/21 Pt admitted for acute respiratory failure and COVID PNA;  Comprehensive problem list: acute hypoxemic respiratory failure, refractory hypoxemia, COVID PNA,  cardiac arrest, coronary artery disease status post CABG, probable pulmonary embolus, colitis, COPD on home O2, chronic hypoxemic resp failure, insulin dependent diabetes mellitus, depression, GERD, hypertension, anxiety and panic attack Pt has end stage renal disease; had fever and weakness; O2 saturation was 70% on 3L cannula that he wore all the time; treated with vapotherm and non-rebreather mass which was ineffective; switched to bipap which worked well in the er; transferred to icu; became hypoxemic; intubated with 7.5 ET tube and arrested 10 min later; cpr ensued, 4 separate codes because of recurrent problems ekg showed some nonspecific st-t changes; heparin given, low oxygen levels that could not be increased, 2nd arrest, cpr given; sister was called, determined that no further cpr would be given; allowed to have continued support until his heart quit and pt passed away.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, SARS-CoV-2 test positive
Clinical narrative: Vaccinated pt admitted for covid pna
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Corrective lens user, Crying, Discomfort, Dry eye
Clinical narrative: Early Fall I had gotten new contact lenses and was comfortably wearing them 10-11 hrs per day; Dr. saw me for f/u and said that they fit well and were being tolerated well.  In December I started to have burning when I put them in and had to wear them less time.  I tried drops or took them out to rewet.  By the end of December I had excruciating burning that made me cry from pain.  I stopped wearing them until I could be seen for f/u on 1/5.  I was told that my eyes were very dry and that  I "can't wear contact lenses"; there was no explanation about the change in my condition.  I was told that perhaps I could wear them 1-2 hrs on special occasions; I tried one more time and the burning was excruciating causing me to cry from discomfort. Only recently did I begin to question if this could be an adverse effect from the vaccine since no other professional could state anything except that I now have exceptionally dry eyes and need to use drops multiple times daily.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Eye complication associated with device, Ophthalmological examination abnormal, Pain
Clinical narrative: Early Fall I had gotten new contact lenses and was comfortably wearing them 10-11 hrs per day; Dr. saw me for f/u and said that they fit well and were being tolerated well.  In December I started to have burning when I put them in and had to wear them less time.  I tried drops or took them out to rewet.  By the end of December I had excruciating burning that made me cry from pain.  I stopped wearing them until I could be seen for f/u on 1/5.  I was told that my eyes were very dry and that  I "can't wear contact lenses"; there was no explanation about the change in my condition.  I was told that perhaps I could wear them 1-2 hrs on special occasions; I tried one more time and the burning was excruciating causing me to cry from discomfort. Only recently did I begin to question if this could be an adverse effect from the vaccine since no other professional could state anything except that I now have exceptionally dry eyes and need to use drops multiple times daily.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives 2 prescriptions of steroids hives will not go away
Age: 42.0
Sex: M
Vaccine: UNK
Symptoms: Extra dose administered
Clinical narrative: patient presented requesting a 2nd dose of moderna vaccine after administrating vaccine we figured the patient is under the influence and after checking impact we found that patient had 5 doses of moderna and when we asked the patient and he said no he had only gotten one before at our location.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Acidosis, Acute kidney injury, Acute respiratory failure, COVID-19, COVID-19 pneumonia
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccine on 1/23/21 and 2/13/21. Admitted 2/23/22 with Covid at local hospital c/b AKI needing CRRT. Transferred to ICU 2/2 renal transplant. Admitted w/acute hypoxic respiratory failure 2/2 Covid PNA and acute encephalopathy. MRI 2/26/21 w/perforated bowel 2/2 right colonic ischemia. Acutely decompensated with a large increase of vasopressor needs and refractory acidosis despite maximized ventilation techniques and CRRT. Transitioned to comfort care and expired on 2/26/22. Treated with vancomycin and Merem at hospital. Treated with vacomycin, cefepime, micafungin, and Cresemba.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Encephalopathy, Haemofiltration, Intensive care, Intestinal ischaemia
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccine on 1/23/21 and 2/13/21. Admitted 2/23/22 with Covid at local hospital c/b AKI needing CRRT. Transferred to ICU 2/2 renal transplant. Admitted w/acute hypoxic respiratory failure 2/2 Covid PNA and acute encephalopathy. MRI 2/26/21 w/perforated bowel 2/2 right colonic ischemia. Acutely decompensated with a large increase of vasopressor needs and refractory acidosis despite maximized ventilation techniques and CRRT. Transitioned to comfort care and expired on 2/26/22. Treated with vancomycin and Merem at hospital. Treated with vacomycin, cefepime, micafungin, and Cresemba.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Intestinal perforation, Mechanical ventilation, Renal transplant, Viral test
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccine on 1/23/21 and 2/13/21. Admitted 2/23/22 with Covid at local hospital c/b AKI needing CRRT. Transferred to ICU 2/2 renal transplant. Admitted w/acute hypoxic respiratory failure 2/2 Covid PNA and acute encephalopathy. MRI 2/26/21 w/perforated bowel 2/2 right colonic ischemia. Acutely decompensated with a large increase of vasopressor needs and refractory acidosis despite maximized ventilation techniques and CRRT. Transitioned to comfort care and expired on 2/26/22. Treated with vancomycin and Merem at hospital. Treated with vacomycin, cefepime, micafungin, and Cresemba.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Pain in extremity
Clinical narrative: After the vaccine I experienced brain fog. It lasted for about three days. Also, sore arm and fatigue.
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Alanine aminotransferase increased, Alpha haemolytic streptococcal infection, Apnoea, Aspartate aminotransferase increased, Bacteraemia
Clinical narrative: Moderna COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccine on 3/19/21 and 4/16/21. Presented to ED 2/22/22 Covid+ in PEA arrest 2/2 septic shock due to polymicrobial PNA and bacteremia 2/2 Streptococcus viridans. Upon arrival to ED he has found to be unresponsive, apnic, and pulseless within vehicle. Rec'd epi x6, bicarb x2 & calcium 1g w/ROSC achieved. Became hypertensive and received Cardizem w/subsequent bradycardia and PEA arrest. ROSC after Epi x 1. Labs significant for BG 299, SrCr 3.4 up from 2.4 in 12/21, AST 168, ALT 104, CRP 11.5, Lactate 7.1 initially 6.1 on recheck, procal 0.17 BNP 1408, Ddimer > 20,  WBC 18.2. Tx'd w/cefepime, vanc and therapeutic cooling, during rewarming he did not have meaningful neurologic activity.  For 24 hours, all sedation was discontinued and he remained in a persistently vegetative state. Transitioned to comfort care, expired 2/25/21.
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood creatinine increased, Blood glucose increased, Blood lactic acid, Bradycardia, Brain natriuretic peptide increased
Clinical narrative: Moderna COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccine on 3/19/21 and 4/16/21. Presented to ED 2/22/22 Covid+ in PEA arrest 2/2 septic shock due to polymicrobial PNA and bacteremia 2/2 Streptococcus viridans. Upon arrival to ED he has found to be unresponsive, apnic, and pulseless within vehicle. Rec'd epi x6, bicarb x2 & calcium 1g w/ROSC achieved. Became hypertensive and received Cardizem w/subsequent bradycardia and PEA arrest. ROSC after Epi x 1. Labs significant for BG 299, SrCr 3.4 up from 2.4 in 12/21, AST 168, ALT 104, CRP 11.5, Lactate 7.1 initially 6.1 on recheck, procal 0.17 BNP 1408, Ddimer > 20,  WBC 18.2. Tx'd w/cefepime, vanc and therapeutic cooling, during rewarming he did not have meaningful neurologic activity.  For 24 hours, all sedation was discontinued and he remained in a persistently vegetative state. Transitioned to comfort care, expired 2/25/21.
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: C-reactive protein increased, COVID-19, Death, Fibrin D dimer, Hypertension
Clinical narrative: Moderna COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccine on 3/19/21 and 4/16/21. Presented to ED 2/22/22 Covid+ in PEA arrest 2/2 septic shock due to polymicrobial PNA and bacteremia 2/2 Streptococcus viridans. Upon arrival to ED he has found to be unresponsive, apnic, and pulseless within vehicle. Rec'd epi x6, bicarb x2 & calcium 1g w/ROSC achieved. Became hypertensive and received Cardizem w/subsequent bradycardia and PEA arrest. ROSC after Epi x 1. Labs significant for BG 299, SrCr 3.4 up from 2.4 in 12/21, AST 168, ALT 104, CRP 11.5, Lactate 7.1 initially 6.1 on recheck, procal 0.17 BNP 1408, Ddimer > 20,  WBC 18.2. Tx'd w/cefepime, vanc and therapeutic cooling, during rewarming he did not have meaningful neurologic activity.  For 24 hours, all sedation was discontinued and he remained in a persistently vegetative state. Transitioned to comfort care, expired 2/25/21.
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pneumonia, Procalcitonin, Pulse absent, Pulseless electrical activity, SARS-CoV-2 test positive
Clinical narrative: Moderna COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccine on 3/19/21 and 4/16/21. Presented to ED 2/22/22 Covid+ in PEA arrest 2/2 septic shock due to polymicrobial PNA and bacteremia 2/2 Streptococcus viridans. Upon arrival to ED he has found to be unresponsive, apnic, and pulseless within vehicle. Rec'd epi x6, bicarb x2 & calcium 1g w/ROSC achieved. Became hypertensive and received Cardizem w/subsequent bradycardia and PEA arrest. ROSC after Epi x 1. Labs significant for BG 299, SrCr 3.4 up from 2.4 in 12/21, AST 168, ALT 104, CRP 11.5, Lactate 7.1 initially 6.1 on recheck, procal 0.17 BNP 1408, Ddimer > 20,  WBC 18.2. Tx'd w/cefepime, vanc and therapeutic cooling, during rewarming he did not have meaningful neurologic activity.  For 24 hours, all sedation was discontinued and he remained in a persistently vegetative state. Transitioned to comfort care, expired 2/25/21.
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Septic shock, Unresponsive to stimuli, White blood cell count increased
Clinical narrative: Moderna COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccine on 3/19/21 and 4/16/21. Presented to ED 2/22/22 Covid+ in PEA arrest 2/2 septic shock due to polymicrobial PNA and bacteremia 2/2 Streptococcus viridans. Upon arrival to ED he has found to be unresponsive, apnic, and pulseless within vehicle. Rec'd epi x6, bicarb x2 & calcium 1g w/ROSC achieved. Became hypertensive and received Cardizem w/subsequent bradycardia and PEA arrest. ROSC after Epi x 1. Labs significant for BG 299, SrCr 3.4 up from 2.4 in 12/21, AST 168, ALT 104, CRP 11.5, Lactate 7.1 initially 6.1 on recheck, procal 0.17 BNP 1408, Ddimer > 20,  WBC 18.2. Tx'd w/cefepime, vanc and therapeutic cooling, during rewarming he did not have meaningful neurologic activity.  For 24 hours, all sedation was discontinued and he remained in a persistently vegetative state. Transitioned to comfort care, expired 2/25/21.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blood test normal, Urticaria chronic
Clinical narrative: Chronic urticaria. Started almost 2 weeks after booster. It persists to this day. At first, it was extremely severe. I was put on Prednisone. After month on Prednisone it has stabilized but hives appear daily. First two weeks, condition was extremely severe and debilitating.
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Skin disorder, Tinnitus
Clinical narrative: my previous bout with Tinnitus has seed to become more amplified since vaccine shots as well as skin issue on a few fingers since vaccine shots.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse event, Death
Clinical narrative: Pt died at home; no recent treatments or visits immediately prior to adverse event.
Age: 46.0
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Vaccinated pt admitted with covid infection
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Abdominal wall haematoma, Acute respiratory failure, Anticoagulant therapy, COVID-19
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccine on 3/18/21, 4/15/21, and 11/08/2021. Admitted 2/9 - 19/22 for acute on chronic COPD exacerbation, tested Covid+ 2/9. Presented back to ED 2/20/22 for worsening pain in abdomen 2/2 abdominal wall hematoma 2/2 anticoagulation, TX'd w/2 uRBCs and 1 uFFP. Course c/b acute on chronic hypoxic respiratory failure. Continued to decline with hypoxia and hypercapnia with worsening mentation. Transitioned to comfort care and transferred to local Care Unit. Expired on 3/01/22.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Chronic obstructive pulmonary disease, Condition aggravated, Death, General physical health deterioration, Haematoma
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccine on 3/18/21, 4/15/21, and 11/08/2021. Admitted 2/9 - 19/22 for acute on chronic COPD exacerbation, tested Covid+ 2/9. Presented back to ED 2/20/22 for worsening pain in abdomen 2/2 abdominal wall hematoma 2/2 anticoagulation, TX'd w/2 uRBCs and 1 uFFP. Course c/b acute on chronic hypoxic respiratory failure. Continued to decline with hypoxia and hypercapnia with worsening mentation. Transitioned to comfort care and transferred to local Care Unit. Expired on 3/01/22.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Hypercapnia, Hypoxia, Inappropriate schedule of product administration, Mental status changes, Red blood cell transfusion
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccine on 3/18/21, 4/15/21, and 11/08/2021. Admitted 2/9 - 19/22 for acute on chronic COPD exacerbation, tested Covid+ 2/9. Presented back to ED 2/20/22 for worsening pain in abdomen 2/2 abdominal wall hematoma 2/2 anticoagulation, TX'd w/2 uRBCs and 1 uFFP. Course c/b acute on chronic hypoxic respiratory failure. Continued to decline with hypoxia and hypercapnia with worsening mentation. Transitioned to comfort care and transferred to local Care Unit. Expired on 3/01/22.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory failure, SARS-CoV-2 test positive, Transfusion
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccine on 3/18/21, 4/15/21, and 11/08/2021. Admitted 2/9 - 19/22 for acute on chronic COPD exacerbation, tested Covid+ 2/9. Presented back to ED 2/20/22 for worsening pain in abdomen 2/2 abdominal wall hematoma 2/2 anticoagulation, TX'd w/2 uRBCs and 1 uFFP. Course c/b acute on chronic hypoxic respiratory failure. Continued to decline with hypoxia and hypercapnia with worsening mentation. Transitioned to comfort care and transferred to local Care Unit. Expired on 3/01/22.
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Pfizer COVID Vaccine EUA: Formulation/Dosage Error. Patient received Pfizer vaccines on 2/12/2022 and 3/5/2022. The product provided on 3/5/2022 was 0.3 ml of the adult formulation.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Bladder catheterisation, Culture urine, Sepsis, Urinary tract infection
Clinical narrative: Severe sepsis due to complicated UTI from indwelling suprapubic catheter. Has been treated with IV fluids. Was initially on Rocephin >> switched to Cipro after urine culture resulted. Patient will complete 14-day course of Cipro. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: vaccinated pt admitted with covid
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram pulmonary normal, Anticoagulant therapy, Atrial fibrillation, Blood creatinine increased, Blood glucose decreased
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 2/16/21 (lot not listed in registry) Pfizer Dose 2 3/9/21 (lot not listed in registry) COVID Positive 10/9/21  10/9/21: Patient is a 81-year-old female with past medical history of morbid obesity, COPD, CKD 2-3, type 2 diabetes, hypertension, hypothyroidism, bilateral lymphedema and venous stasis, recent diagnosis of PE on anticoagulation, recent gastric ulcer was brought in from nursing home for hypotension.  History is obtained from patient's daughter, patient her medical records.  It appears that this morning patient was found to be hypotensive by staff and was brought to the ED.  It appears patient was on oxygen at nursing home and patient and family is not sure. Patient denies any chest pain, headache, dizziness, shortness of breath, nausea, vomiting, abdomen pain, dark stool or hematemesis.  Patient was recently admitted and was found to have a new PE was put on anticoagulation.  Patient had subsequent bleeding GI was consulted.  Patient was found to have the small gastric ulcer.   In the ED BP 104/29, HR 93, Temp 97.7, 100 % on 3 L NC. EKG showed AFib rate of 97. Creatinine 1.79, proBNP 1800, hemoglobin 6.6. fecal occult positive.  Patient received 1 unit of RBC in the ED.  GI consulted. BG dropped  10/16/21: Pt was admitted and underwent endoscopy evaluation with GI for acute blood loss anemia that resolved sp PRBC transfusion  There was initial concern for PE per VQ scan however CTPA negative for PE  Pt with elevated risk of bleeding including a history of gastric ulcer. Eliquis was on hold  She was treatd for mild COVID 19 infection. Remains on baseline O2 requirement  Wound care for chronic wounds by wound nurses  Home medications resumed as appropriate  Home hypoglycemics were on hold. Accucheks and insubq regimen was implemented  Patient discharged to SNF in stable conditions  Total time spent on d/c 45 min
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Blood loss anaemia, COVID-19, Electrocardiogram abnormal, Endoscopy abnormal, Gastric ulcer
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 2/16/21 (lot not listed in registry) Pfizer Dose 2 3/9/21 (lot not listed in registry) COVID Positive 10/9/21  10/9/21: Patient is a 81-year-old female with past medical history of morbid obesity, COPD, CKD 2-3, type 2 diabetes, hypertension, hypothyroidism, bilateral lymphedema and venous stasis, recent diagnosis of PE on anticoagulation, recent gastric ulcer was brought in from nursing home for hypotension.  History is obtained from patient's daughter, patient her medical records.  It appears that this morning patient was found to be hypotensive by staff and was brought to the ED.  It appears patient was on oxygen at nursing home and patient and family is not sure. Patient denies any chest pain, headache, dizziness, shortness of breath, nausea, vomiting, abdomen pain, dark stool or hematemesis.  Patient was recently admitted and was found to have a new PE was put on anticoagulation.  Patient had subsequent bleeding GI was consulted.  Patient was found to have the small gastric ulcer.   In the ED BP 104/29, HR 93, Temp 97.7, 100 % on 3 L NC. EKG showed AFib rate of 97. Creatinine 1.79, proBNP 1800, hemoglobin 6.6. fecal occult positive.  Patient received 1 unit of RBC in the ED.  GI consulted. BG dropped  10/16/21: Pt was admitted and underwent endoscopy evaluation with GI for acute blood loss anemia that resolved sp PRBC transfusion  There was initial concern for PE per VQ scan however CTPA negative for PE  Pt with elevated risk of bleeding including a history of gastric ulcer. Eliquis was on hold  She was treatd for mild COVID 19 infection. Remains on baseline O2 requirement  Wound care for chronic wounds by wound nurses  Home medications resumed as appropriate  Home hypoglycemics were on hold. Accucheks and insubq regimen was implemented  Patient discharged to SNF in stable conditions  Total time spent on d/c 45 min
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Haemoglobin decreased, Haemorrhage, Hypotension, Occult blood positive, Prohormone brain natriuretic peptide increased
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 2/16/21 (lot not listed in registry) Pfizer Dose 2 3/9/21 (lot not listed in registry) COVID Positive 10/9/21  10/9/21: Patient is a 81-year-old female with past medical history of morbid obesity, COPD, CKD 2-3, type 2 diabetes, hypertension, hypothyroidism, bilateral lymphedema and venous stasis, recent diagnosis of PE on anticoagulation, recent gastric ulcer was brought in from nursing home for hypotension.  History is obtained from patient's daughter, patient her medical records.  It appears that this morning patient was found to be hypotensive by staff and was brought to the ED.  It appears patient was on oxygen at nursing home and patient and family is not sure. Patient denies any chest pain, headache, dizziness, shortness of breath, nausea, vomiting, abdomen pain, dark stool or hematemesis.  Patient was recently admitted and was found to have a new PE was put on anticoagulation.  Patient had subsequent bleeding GI was consulted.  Patient was found to have the small gastric ulcer.   In the ED BP 104/29, HR 93, Temp 97.7, 100 % on 3 L NC. EKG showed AFib rate of 97. Creatinine 1.79, proBNP 1800, hemoglobin 6.6. fecal occult positive.  Patient received 1 unit of RBC in the ED.  GI consulted. BG dropped  10/16/21: Pt was admitted and underwent endoscopy evaluation with GI for acute blood loss anemia that resolved sp PRBC transfusion  There was initial concern for PE per VQ scan however CTPA negative for PE  Pt with elevated risk of bleeding including a history of gastric ulcer. Eliquis was on hold  She was treatd for mild COVID 19 infection. Remains on baseline O2 requirement  Wound care for chronic wounds by wound nurses  Home medications resumed as appropriate  Home hypoglycemics were on hold. Accucheks and insubq regimen was implemented  Patient discharged to SNF in stable conditions  Total time spent on d/c 45 min
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Red blood cell transfusion, SARS-CoV-2 test positive, Specialist consultation, Vaccine breakthrough infection, Ventilation/perfusion scan
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 2/16/21 (lot not listed in registry) Pfizer Dose 2 3/9/21 (lot not listed in registry) COVID Positive 10/9/21  10/9/21: Patient is a 81-year-old female with past medical history of morbid obesity, COPD, CKD 2-3, type 2 diabetes, hypertension, hypothyroidism, bilateral lymphedema and venous stasis, recent diagnosis of PE on anticoagulation, recent gastric ulcer was brought in from nursing home for hypotension.  History is obtained from patient's daughter, patient her medical records.  It appears that this morning patient was found to be hypotensive by staff and was brought to the ED.  It appears patient was on oxygen at nursing home and patient and family is not sure. Patient denies any chest pain, headache, dizziness, shortness of breath, nausea, vomiting, abdomen pain, dark stool or hematemesis.  Patient was recently admitted and was found to have a new PE was put on anticoagulation.  Patient had subsequent bleeding GI was consulted.  Patient was found to have the small gastric ulcer.   In the ED BP 104/29, HR 93, Temp 97.7, 100 % on 3 L NC. EKG showed AFib rate of 97. Creatinine 1.79, proBNP 1800, hemoglobin 6.6. fecal occult positive.  Patient received 1 unit of RBC in the ED.  GI consulted. BG dropped  10/16/21: Pt was admitted and underwent endoscopy evaluation with GI for acute blood loss anemia that resolved sp PRBC transfusion  There was initial concern for PE per VQ scan however CTPA negative for PE  Pt with elevated risk of bleeding including a history of gastric ulcer. Eliquis was on hold  She was treatd for mild COVID 19 infection. Remains on baseline O2 requirement  Wound care for chronic wounds by wound nurses  Home medications resumed as appropriate  Home hypoglycemics were on hold. Accucheks and insubq regimen was implemented  Patient discharged to SNF in stable conditions  Total time spent on d/c 45 min
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Wound, Wound treatment
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 2/16/21 (lot not listed in registry) Pfizer Dose 2 3/9/21 (lot not listed in registry) COVID Positive 10/9/21  10/9/21: Patient is a 81-year-old female with past medical history of morbid obesity, COPD, CKD 2-3, type 2 diabetes, hypertension, hypothyroidism, bilateral lymphedema and venous stasis, recent diagnosis of PE on anticoagulation, recent gastric ulcer was brought in from nursing home for hypotension.  History is obtained from patient's daughter, patient her medical records.  It appears that this morning patient was found to be hypotensive by staff and was brought to the ED.  It appears patient was on oxygen at nursing home and patient and family is not sure. Patient denies any chest pain, headache, dizziness, shortness of breath, nausea, vomiting, abdomen pain, dark stool or hematemesis.  Patient was recently admitted and was found to have a new PE was put on anticoagulation.  Patient had subsequent bleeding GI was consulted.  Patient was found to have the small gastric ulcer.   In the ED BP 104/29, HR 93, Temp 97.7, 100 % on 3 L NC. EKG showed AFib rate of 97. Creatinine 1.79, proBNP 1800, hemoglobin 6.6. fecal occult positive.  Patient received 1 unit of RBC in the ED.  GI consulted. BG dropped  10/16/21: Pt was admitted and underwent endoscopy evaluation with GI for acute blood loss anemia that resolved sp PRBC transfusion  There was initial concern for PE per VQ scan however CTPA negative for PE  Pt with elevated risk of bleeding including a history of gastric ulcer. Eliquis was on hold  She was treatd for mild COVID 19 infection. Remains on baseline O2 requirement  Wound care for chronic wounds by wound nurses  Home medications resumed as appropriate  Home hypoglycemics were on hold. Accucheks and insubq regimen was implemented  Patient discharged to SNF in stable conditions  Total time spent on d/c 45 min
Age: 1.0
Sex: F
Vaccine: MMR
Symptoms: Rash
Clinical narrative: Mother reported that she developed a full body rash 12 days after the vaccine was administered. She reported that the rash lasted 24 hours and did not seem bothersome.  Denies any other symptoms.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Anticoagulant therapy, Asthenia, Blood lactic acid, Blood pH increased
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 3/12/21 (EN6203) Pfizer Dose 2 4/7/21 (ER8737) Pfizer Dose 3 8/23/21 (EW0177) COVID Positive 10/13/21  10/13/21: 78-year-old female with rheumatoid arthritis on Rituxan and leflunomide, interstitial lung disease, chronic hypoxic respiratory failure on 2 L home oxygen, hypertension and hyperlipidemia presented with worsening shortness of breath and cough.  Patient had been hospitalized twice in the past 3 weeks initially with community-acquired pneumonia, later for MRSA pneumonia and influenza, discharged home on 10/06/2021 with oral doxycycline and 2 L nasal cannula oxygen.  Reports she felt better for few days after discharge and started having worsening shortness of breath, cough productive of yellowish sputum, fever with chills.  She has decreased energy and poor appetite.  Denies any chest pain, palpitation or dizziness.  No nausea, vomiting or abdominal pain.  Patient was reportedly saturating 60% on 4 L home oxygen when EMS arrived and had respiratory distress, placed on CPAP In the ED she had a T-max of 103.4°, heart rate is 130, respiratory rate 43 , blood pressure 96 over cysts 6. She was placed on BiPAP with significant improvement in her respiratory distress and shortness of breath.  WBC 4.7, lactic acid 3.0, pH 7.48 pCO2 20, PO2 97 patient chest x-ray showing bilateral infiltrates.  Patient received vancomycin and Zosyn, IV fluids, 125 mg of Solu-Medrol and 2 g of magnesium sulfate as well as DuoNeb.  10/26/21: Acute hypoxic respiratory failure currently on 8 L of oxygen via   OxyMask on top of 6 L of oxygen via nasal cannula.  Baseline she is on 2 L of oxygen.  COVID-19 pneumonia, slowly resolving but patient becomes hypoxic and desaturates easily with physical exertion. Patient currently on tapering dose of Decadron and levofloxacin oral.  Completed dose of remdesivir.  Elevated D-dimer previously on heparin infusion but now on apixaban 2.5 mg p.o. b.i.d..  Purpuric lesions on the skin, patient treated with acyclovir but not sure if it is herpetic.  Moderate to severe MR with normal LV function.  Repeat echocardiogram done on 10/24/2021 was inconclusive because of very poor echo window.  Interstitial lung disease/Pulmonary fibrosis patient on 2 L of oxygen at home.  Rheumatoid arthritis on leflunomide and Rituxan.  Recent MRSA pneumonia on 09/30/2021 treated with doxycycline per ID recommendation.  Enterobacter pneumonia on Levaquin.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Chills, Condition aggravated
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 3/12/21 (EN6203) Pfizer Dose 2 4/7/21 (ER8737) Pfizer Dose 3 8/23/21 (EW0177) COVID Positive 10/13/21  10/13/21: 78-year-old female with rheumatoid arthritis on Rituxan and leflunomide, interstitial lung disease, chronic hypoxic respiratory failure on 2 L home oxygen, hypertension and hyperlipidemia presented with worsening shortness of breath and cough.  Patient had been hospitalized twice in the past 3 weeks initially with community-acquired pneumonia, later for MRSA pneumonia and influenza, discharged home on 10/06/2021 with oral doxycycline and 2 L nasal cannula oxygen.  Reports she felt better for few days after discharge and started having worsening shortness of breath, cough productive of yellowish sputum, fever with chills.  She has decreased energy and poor appetite.  Denies any chest pain, palpitation or dizziness.  No nausea, vomiting or abdominal pain.  Patient was reportedly saturating 60% on 4 L home oxygen when EMS arrived and had respiratory distress, placed on CPAP In the ED she had a T-max of 103.4°, heart rate is 130, respiratory rate 43 , blood pressure 96 over cysts 6. She was placed on BiPAP with significant improvement in her respiratory distress and shortness of breath.  WBC 4.7, lactic acid 3.0, pH 7.48 pCO2 20, PO2 97 patient chest x-ray showing bilateral infiltrates.  Patient received vancomycin and Zosyn, IV fluids, 125 mg of Solu-Medrol and 2 g of magnesium sulfate as well as DuoNeb.  10/26/21: Acute hypoxic respiratory failure currently on 8 L of oxygen via   OxyMask on top of 6 L of oxygen via nasal cannula.  Baseline she is on 2 L of oxygen.  COVID-19 pneumonia, slowly resolving but patient becomes hypoxic and desaturates easily with physical exertion. Patient currently on tapering dose of Decadron and levofloxacin oral.  Completed dose of remdesivir.  Elevated D-dimer previously on heparin infusion but now on apixaban 2.5 mg p.o. b.i.d..  Purpuric lesions on the skin, patient treated with acyclovir but not sure if it is herpetic.  Moderate to severe MR with normal LV function.  Repeat echocardiogram done on 10/24/2021 was inconclusive because of very poor echo window.  Interstitial lung disease/Pulmonary fibrosis patient on 2 L of oxygen at home.  Rheumatoid arthritis on leflunomide and Rituxan.  Recent MRSA pneumonia on 09/30/2021 treated with doxycycline per ID recommendation.  Enterobacter pneumonia on Levaquin.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Decreased appetite, Dyspnoea, Echocardiogram, Enterobacter pneumonia
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 3/12/21 (EN6203) Pfizer Dose 2 4/7/21 (ER8737) Pfizer Dose 3 8/23/21 (EW0177) COVID Positive 10/13/21  10/13/21: 78-year-old female with rheumatoid arthritis on Rituxan and leflunomide, interstitial lung disease, chronic hypoxic respiratory failure on 2 L home oxygen, hypertension and hyperlipidemia presented with worsening shortness of breath and cough.  Patient had been hospitalized twice in the past 3 weeks initially with community-acquired pneumonia, later for MRSA pneumonia and influenza, discharged home on 10/06/2021 with oral doxycycline and 2 L nasal cannula oxygen.  Reports she felt better for few days after discharge and started having worsening shortness of breath, cough productive of yellowish sputum, fever with chills.  She has decreased energy and poor appetite.  Denies any chest pain, palpitation or dizziness.  No nausea, vomiting or abdominal pain.  Patient was reportedly saturating 60% on 4 L home oxygen when EMS arrived and had respiratory distress, placed on CPAP In the ED she had a T-max of 103.4°, heart rate is 130, respiratory rate 43 , blood pressure 96 over cysts 6. She was placed on BiPAP with significant improvement in her respiratory distress and shortness of breath.  WBC 4.7, lactic acid 3.0, pH 7.48 pCO2 20, PO2 97 patient chest x-ray showing bilateral infiltrates.  Patient received vancomycin and Zosyn, IV fluids, 125 mg of Solu-Medrol and 2 g of magnesium sulfate as well as DuoNeb.  10/26/21: Acute hypoxic respiratory failure currently on 8 L of oxygen via   OxyMask on top of 6 L of oxygen via nasal cannula.  Baseline she is on 2 L of oxygen.  COVID-19 pneumonia, slowly resolving but patient becomes hypoxic and desaturates easily with physical exertion. Patient currently on tapering dose of Decadron and levofloxacin oral.  Completed dose of remdesivir.  Elevated D-dimer previously on heparin infusion but now on apixaban 2.5 mg p.o. b.i.d..  Purpuric lesions on the skin, patient treated with acyclovir but not sure if it is herpetic.  Moderate to severe MR with normal LV function.  Repeat echocardiogram done on 10/24/2021 was inconclusive because of very poor echo window.  Interstitial lung disease/Pulmonary fibrosis patient on 2 L of oxygen at home.  Rheumatoid arthritis on leflunomide and Rituxan.  Recent MRSA pneumonia on 09/30/2021 treated with doxycycline per ID recommendation.  Enterobacter pneumonia on Levaquin.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Fibrin D dimer increased, Inappropriate schedule of product administration, Influenza, Lung infiltration, Mitral valve incompetence
Clinical narrative: COVID Breakthrough Case  Pfizer Dose 1 3/12/21 (EN6203) Pfizer Dose 2 4/7/21 (ER8737) Pfizer Dose 3 8/23/21 (EW0177) COVID Positive 10/13/21  10/13/21: 78-year-old female with rheumatoid arthritis on Rituxan and leflunomide, interstitial lung disease, chronic hypoxic respiratory failure on 2 L home oxygen, hypertension and hyperlipidemia presented with worsening shortness of breath and cough.  Patient had been hospitalized twice in the past 3 weeks initially with community-acquired pneumonia, later for MRSA pneumonia and influenza, discharged home on 10/06/2021 with oral doxycycline and 2 L nasal cannula oxygen.  Reports she felt better for few days after discharge and started having worsening shortness of breath, cough productive of yellowish sputum, fever with chills.  She has decreased energy and poor appetite.  Denies any chest pain, palpitation or dizziness.  No nausea, vomiting or abdominal pain.  Patient was reportedly saturating 60% on 4 L home oxygen when EMS arrived and had respiratory distress, placed on CPAP In the ED she had a T-max of 103.4°, heart rate is 130, respiratory rate 43 , blood pressure 96 over cysts 6. She was placed on BiPAP with significant improvement in her respiratory distress and shortness of breath.  WBC 4.7, lactic acid 3.0, pH 7.48 pCO2 20, PO2 97 patient chest x-ray showing bilateral infiltrates.  Patient received vancomycin and Zosyn, IV fluids, 125 mg of Solu-Medrol and 2 g of magnesium sulfate as well as DuoNeb.  10/26/21: Acute hypoxic respiratory failure currently on 8 L of oxygen via   OxyMask on top of 6 L of oxygen via nasal cannula.  Baseline she is on 2 L of oxygen.  COVID-19 pneumonia, slowly resolving but patient becomes hypoxic and desaturates easily with physical exertion. Patient currently on tapering dose of Decadron and levofloxacin oral.  Completed dose of remdesivir.  Elevated D-dimer previously on heparin infusion but now on apixaban 2.5 mg p.o. b.i.d..  Purpuric lesions on the skin, patient treated with acyclovir but not sure if it is herpetic.  Moderate to severe MR with normal LV function.  Repeat echocardiogram done on 10/24/2021 was inconclusive because of very poor echo window.  Interstitial lung disease/Pulmonary fibrosis patient on 2 L of oxygen at home.  Rheumatoid arthritis on leflunomide and Rituxan.  Recent MRSA pneumonia on 09/30/2021 treated with doxycycline per ID recommendation.  Enterobacter pneumonia on Levaquin.